In a strategic move to expand its footprint in the paediatric and wellness segment, Cipla Limited has announced the acquisition of Inzpera Healthsciences Ltd for ₹110.65 crore. The acquisition underscores Cipla’s continued focus on diversified consumer healthcare solutions, particularly in the areas of child nutrition, gut